Clin2
NCT07110766Possibly a fitNot yet recruiting

Study of MDR-001 for weight loss in people with obesity or overweight

Obesity &Amp; Overweight

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests an experimental drug called MDR-001 to see if it can help people with obesity or overweight lose weight. It may be an option for you if you have weight-related health issues like high blood sugar, high blood pressure, or fatty liver.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are Chinese and live in China.
  • You have a body mass index (BMI) of 28 or higher, or a BMI between 24 and 28 with at least one weight-related health problem like pre-diabetes, high blood pressure, high cholesterol, fatty liver, sleep apnea, or joint pain.
  • Your weight has been stable (no more than 5% change) for the past 3 months.
  • You are willing to use effective birth control during the study and for 6 months after, if applicable.
  • You do not have diabetes, a history of certain heart problems, or other serious health conditions listed in the full criteria.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07274137Not yet recruiting· Phase 3
A new weight-loss medicine for adults with overweight or obesity

This study tests a new weight-loss medicine called MDR-001 in adults who are overweight or have obesity. It aims to see if the medicine is safe and helps people lose weight.

Beijing
NCT07279194Recruiting· Phase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes

This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.

Shanghai
NCT07845513Not yet recruiting· Phase 1
Study of a new weight-loss medicine in Chinese adults

This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.

Beijing, Beijing Municipality
NCT06924320Recruiting· Phase 1/Phase 2
Study of two medicines for weight loss and diabetes

This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.

Cypress, California
NCT07518589Not yet recruiting· Phase 1
Weight loss drug study for overweight adults

This study tests a new medication called CMS-D008 to see if it can help with weight loss in overweight or obese adults. It is an early-stage trial, so the main goals are to check safety and how the body handles the drug.

NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida

Hear when a new Obesity &Amp; Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.